비교리스트

 카트 문의
시장보고서
상품코드
1559403

세계의 의약품 수탁제조 시장(2024-2028년)

Global Pharmaceutical Contract Manufacturing Market 2024-2028
발행일: | 리서치사: TechNavio | 페이지 정보: 영문 164 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의약품 수탁제조 시장은 2023-2028년간 648억 달러 확대되고, 예측 기간 동안 8.1%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 이 보고서는 의약품 수탁제조 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 특허 만료, 제네릭 의약품에 대한 수요 증가, 핵심 역량에 대한 집중 요구 증가, 강력한 연구 자금 등이 시장을 주도하고 있습니다.

시장 범위
기준년도 2024년
종료년도 2028년
예측 기간 2024-2028년
성장 모멘텀 가속
2024년 전년 대비 7.35%
CAGR 8.1%
증분 금액 648억 달러

이 보고서는 향후 수년간 의약품 수탁제조 시장의 성장을 가속하는 주요 요인 중 하나로 미국 FDA 승인 제조 시설 증가를 꼽았습니다. 또한, 생물학적 치료제에 대한 수요 증가와 빅데이터의 출현은 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 생태계
  • 시장 특징
  • 밸류체인 분석

제3장 시장 규모 평가

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모(2023년)
  • 시장 전망(2023-2028년)

제4장 시장 규모 실적

  • 세계의 의약품 수탁 제조 시장(2018-2022년)
  • 최종사용자별 부문 분석(2018-2022년)
  • 서비스별 부문 분석(2018-2022년)
  • 지역별 부문 분석(2018-2022년)
  • 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁 위협
  • 시장 현황

제6장 시장 세분화 : 최종사용자별

  • 시장 세분화
  • 비교 : 최종사용자별
  • 대규모 제약 기업 : 시장 규모와 예측(2023-2028년)
  • 중소규모 제약 기업 : 시장 규모와 예측(2023-2028년)
  • 제네릭 의약품 기업 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 최종사용자별

제7장 시장 세분화 : 서비스별

  • 시장 세분화
  • 비교 : 서비스별
  • API/원료의약품 제조 : 시장 규모와 예측(2023-2028년)
  • 최종 제형 : 시장 규모와 예측(2023-2028년)
  • 2차 포장 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 서비스별

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2023-2028년)
  • 아시아 : 시장 규모와 예측(2023-2028년)
  • 유럽 : 시장 규모와 예측(2023-2028년)
  • 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
  • 미국 : 시장 규모와 예측(2023-2028년)
  • 중국 : 시장 규모와 예측(2023-2028년)
  • 인도 : 시장 규모와 예측(2023-2028년)
  • 독일 : 시장 규모와 예측(2023-2028년)
  • 영국 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제, 기회, 억제요인

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 기회, 성장 억제요인

제11장 경쟁 구도

  • 개요
  • 경쟁 구도
  • 혼란 상황
  • 업계 리스크

제12장 경쟁 분석

  • 기업 개요
  • 기업의 시장 포지셔닝
  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • Charles River Laboratories International Inc.
  • Cmic Holdings Co. Ltd
  • Dr Reddys Laboratories Ltd.
  • Laboratory Corp. of America Holdings
  • Lonza Group Ltd.
  • Lupin Ltd.
  • OPTIMAPHARM d.o.o.
  • Parexel International Corp.
  • PCI Pharma Services
  • Recipharm AB
  • Syneos Health Inc.
  • Thermo Fisher Scientific Inc.

제13장 부록

LSH 24.10.23

Pharmaceutical Contract Manufacturing Market 2024-2028

The pharmaceutical contract manufacturing market is forecasted to grow by USD 64.8 bn during 2023-2028, accelerating at a CAGR of 8.1% during the forecast period. The report on the pharmaceutical contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patent expiry and increasing demand for generic drugs, growing need to focus on core competencies, and strong research funding.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.35%
CAGR8.1%
Incremental Value$64.8 bn

Technavio's pharmaceutical contract manufacturing market is segmented as below:

By End-user

    • Big pharmaceutical companies
    • Small and medium-sized pharmaceutical companies
    • Generic pharmaceutical companies

By Service

    • API/bulk drug manufacturing
    • Final dosage form
    • Secondary packaging

By Geographical Landscape

    • North America
    • Asia
    • Europe
    • Rest of World (ROW)

This study identifies the increasing number of US fda-approved manufacturing facilities as one of the prime reasons driving the pharmaceutical contract manufacturing market growth during the next few years. Also, rising demand for biological therapies and advent of big data will lead to sizable demand in the market.

The report on the pharmaceutical contract manufacturing market covers the following areas:

    • Pharmaceutical contract manufacturing market sizing
    • Pharmaceutical contract manufacturing market forecast
    • Pharmaceutical contract manufacturing market industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical contract manufacturing market vendors that include AbbVie Inc., Almac Group Ltd., Baxter International Inc., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd, Dalton Pharma Services, DR Reddys Laboratories Ltd., Grifols SA, Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, OPTIMAPHARM d.o.o., Parexel International Corp., PCI Pharma Services, Recipharm AB, Syneos Health Inc., and Thermo Fisher Scientific Inc.. Also, the pharmaceutical contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Service
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Pharmaceutical Contract Manufacturing Market 2018 - 2022
    • Historic Market Size - Data Table on Global Pharmaceutical Contract Manufacturing Market 2018 - 2022 ($ billion)
  • 4.2 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
  • 4.3 Service segment analysis 2018 - 2022
    • Historic Market Size - Service Segment 2018 - 2022 ($ billion)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

  • 6.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 6.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 6.3 Big pharmaceutical companies - Market size and forecast 2023-2028
    • Chart on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
    • Chart on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
    • Data Table on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • 6.4 Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028
    • Chart on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
    • Chart on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
    • Data Table on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • 6.5 Generic pharmaceutical companies - Market size and forecast 2023-2028
    • Chart on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
    • Chart on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
    • Data Table on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by End-user
    • Market opportunity by End-user ($ billion)
    • Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Service

  • 7.1 Market segments
    • Chart on Service - Market share 2023-2028 (%)
    • Data Table on Service - Market share 2023-2028 (%)
  • 7.2 Comparison by Service
    • Chart on Comparison by Service
    • Data Table on Comparison by Service
  • 7.3 API/bulk drug manufacturing - Market size and forecast 2023-2028
    • Chart on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion)
    • Data Table on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion)
    • Chart on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%)
    • Data Table on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%)
  • 7.4 Final dosage form - Market size and forecast 2023-2028
    • Chart on Final dosage form - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Final dosage form - Market size and forecast 2023-2028 ($ billion)
    • Chart on Final dosage form - Year-over-year growth 2023-2028 (%)
    • Data Table on Final dosage form - Year-over-year growth 2023-2028 (%)
  • 7.5 Secondary packaging - Market size and forecast 2023-2028
    • Chart on Secondary packaging - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Secondary packaging - Market size and forecast 2023-2028 ($ billion)
    • Chart on Secondary packaging - Year-over-year growth 2023-2028 (%)
    • Data Table on Secondary packaging - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by Service
    • Market opportunity by Service ($ billion)
    • Data Table on Market opportunity by Service ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.5 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ billion)
    • Data Table on US - Market size and forecast 2023-2028 ($ billion)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ billion)
    • Data Table on China - Market size and forecast 2023-2028 ($ billion)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.9 India - Market size and forecast 2023-2028
    • Chart on India - Market size and forecast 2023-2028 ($ billion)
    • Data Table on India - Market size and forecast 2023-2028 ($ billion)
    • Chart on India - Year-over-year growth 2023-2028 (%)
    • Data Table on India - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ billion)
    • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Almac Group Ltd.
    • Almac Group Ltd. - Overview
    • Almac Group Ltd. - Product / Service
    • Almac Group Ltd. - Key offerings
  • 12.4 Boehringer Ingelheim International GmbH
    • Boehringer Ingelheim International GmbH - Overview
    • Boehringer Ingelheim International GmbH - Product / Service
    • Boehringer Ingelheim International GmbH - Key news
    • Boehringer Ingelheim International GmbH - Key offerings
  • 12.5 Cadila Pharmaceuticals Ltd.
    • Cadila Pharmaceuticals Ltd. - Overview
    • Cadila Pharmaceuticals Ltd. - Product / Service
    • Cadila Pharmaceuticals Ltd. - Key offerings
  • 12.6 Charles River Laboratories International Inc.
    • Charles River Laboratories International Inc. - Overview
    • Charles River Laboratories International Inc. - Business segments
    • Charles River Laboratories International Inc. - Key offerings
    • Charles River Laboratories International Inc. - Segment focus
  • 12.7 Cmic Holdings Co. Ltd
    • Cmic Holdings Co. Ltd - Overview
    • Cmic Holdings Co. Ltd - Business segments
    • Cmic Holdings Co. Ltd - Key offerings
    • Cmic Holdings Co. Ltd - Segment focus
  • 12.8 Dr Reddys Laboratories Ltd.
    • Dr Reddys Laboratories Ltd. - Overview
    • Dr Reddys Laboratories Ltd. - Business segments
    • Dr Reddys Laboratories Ltd. - Key news
    • Dr Reddys Laboratories Ltd. - Key offerings
    • Dr Reddys Laboratories Ltd. - Segment focus
  • 12.9 Laboratory Corp. of America Holdings
    • Laboratory Corp. of America Holdings - Overview
    • Laboratory Corp. of America Holdings - Business segments
    • Laboratory Corp. of America Holdings - Key news
    • Laboratory Corp. of America Holdings - Key offerings
    • Laboratory Corp. of America Holdings - Segment focus
  • 12.10 Lonza Group Ltd.
    • Lonza Group Ltd. - Overview
    • Lonza Group Ltd. - Business segments
    • Lonza Group Ltd. - Key news
    • Lonza Group Ltd. - Key offerings
    • Lonza Group Ltd. - Segment focus
  • 12.11 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
  • 12.12 OPTIMAPHARM d.o.o.
    • OPTIMAPHARM d.o.o. - Overview
    • OPTIMAPHARM d.o.o. - Product / Service
    • OPTIMAPHARM d.o.o. - Key offerings
  • 12.13 Parexel International Corp.
    • Parexel International Corp. - Overview
    • Parexel International Corp. - Product / Service
    • Parexel International Corp. - Key offerings
  • 12.14 PCI Pharma Services
    • PCI Pharma Services - Overview
    • PCI Pharma Services - Product / Service
    • PCI Pharma Services - Key offerings
  • 12.15 Recipharm AB
    • Recipharm AB - Overview
    • Recipharm AB - Business segments
    • Recipharm AB - Key offerings
    • Recipharm AB - Segment focus
  • 12.16 Syneos Health Inc.
    • Syneos Health Inc. - Overview
    • Syneos Health Inc. - Product / Service
    • Syneos Health Inc. - Key offerings
  • 12.17 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제